Surfactant vesicles for enhanced antitoxoplasmic effect of norfloxacin: In vitro and in vivo evaluations-Reference-Cited by-同舟云学术

Surfactant vesicles for enhanced antitoxoplasmic effect of norfloxacin: In vitro and in vivo evaluations

Published:2023-05 Issue: Volume:638 Page:122912
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Eid Rania K.,Arafa Mona F.^ORCID,Ashour Dalia S.,Essa Ebtessam A.,El-Wakil Eman S.^ORCID,Younis Salwa S.,El Maghraby Gamal M.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference63 articles.

1. Optimization of niosomes for enhanced antibacterial activity and reduced bacterial resistance: in vitro and in vivo evaluation;Abdelaziz;Expert Opin. Drug Deliv.,2015

2. Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir;Akhter;Drug Dev. Ind. Pharm.,2012

3. Drugs in development for toxoplasmosis: advances, challenges, and current status;Alday;Drug Des. Devel. Ther.,2017

4. Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge;Arzani;Int. J. Nanomedicine,2015

5. The molecular basis of sulfonamide resistance in toxoplasma gondii and implications for the clinical management of toxoplasmosis;Aspinall;J. Infect. Dis.,2002

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transdermal delivery of resveratrol loaded solid lipid nanoparticle as a microneedle patch: a novel approach for the treatment of Parkinson’s disease;Drug Delivery and Translational Research;2024-06-29

2. Water in nigella oil microemulsion for enhanced oral bioavailability of linagliptin;Drug Delivery and Translational Research;2024-05-13

3. Spectroscopic behavior of bufotenine and bufotenine N-oxide: Solvent and pH effects and interaction with biomembrane models;Biochimica et Biophysica Acta (BBA) - Biomembranes;2024-04

4. Fexofenadine-loaded chitosan coated solid lipid nanoparticles (SLNs): A potential oral therapy for ulcerative colitis;European Journal of Pharmaceutics and Biopharmaceutics;2024-03

5. Application of Design of Experiment in the Optimization of Apixaban-Loaded Solid Lipid Nanoparticles: In Vitro and In Vivo Evaluation;AAPS PharmSciTech;2023-08-08